316 related articles for article (PubMed ID: 29444806)
1. Multiple Applications of a Transient CRISPR-Cas9 Coupled with Electroporation (TRACE) System in the
Fan Y; Lin X
Genetics; 2018 Apr; 208(4):1357-1372. PubMed ID: 29444806
[No Abstract] [Full Text] [Related]
2. Transformation of Cryptococcus neoformans by electroporation using a transient CRISPR-Cas9 expression (TRACE) system.
Lin J; Fan Y; Lin X
Fungal Genet Biol; 2020 May; 138():103364. PubMed ID: 32142753
[TBL] [Abstract][Full Text] [Related]
3. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
4. A 'suicide' CRISPR-Cas9 system to promote gene deletion and restoration by electroporation in Cryptococcus neoformans.
Wang Y; Wei D; Zhu X; Pan J; Zhang P; Huo L; Zhu X
Sci Rep; 2016 Aug; 6():31145. PubMed ID: 27503169
[TBL] [Abstract][Full Text] [Related]
5. Generation of stable mutants and targeted gene deletion strains in Cryptococcus neoformans through electroporation.
Lin X; Chacko N; Wang L; Pavuluri Y
Med Mycol; 2015 Apr; 53(3):225-34. PubMed ID: 25541555
[TBL] [Abstract][Full Text] [Related]
6. Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformans.
Arras SD; Chua SM; Wizrah MS; Faint JA; Yap AS; Fraser JA
PLoS One; 2016; 11(10):e0164322. PubMed ID: 27711143
[TBL] [Abstract][Full Text] [Related]
7. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
[TBL] [Abstract][Full Text] [Related]
8. Biolistic Transformation of Cryptococcus neoformans.
Toffaletti DL; Tenor JL; Perfect JR
Methods Mol Biol; 2024; 2775():59-79. PubMed ID: 38758311
[TBL] [Abstract][Full Text] [Related]
9. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
Najah S; Saulnier C; Pernodet JL; Bury-Moné S
BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
[TBL] [Abstract][Full Text] [Related]
10. An intergenic "safe haven" region in Cryptococcus neoformans serotype D genomes.
Fan Y; Lin X
Fungal Genet Biol; 2020 Nov; 144():103464. PubMed ID: 32947034
[TBL] [Abstract][Full Text] [Related]
11. Gene disruption by biolistic transformation in serotype D strains of Cryptococcus neoformans.
Davidson RC; Cruz MC; Sia RA; Allen B; Alspaugh JA; Heitman J
Fungal Genet Biol; 2000 Feb; 29(1):38-48. PubMed ID: 10779398
[TBL] [Abstract][Full Text] [Related]
12. The CRISPR toolbox in medical mycology: State of the art and perspectives.
Morio F; Lombardi L; Butler G
PLoS Pathog; 2020 Jan; 16(1):e1008201. PubMed ID: 31945142
[TBL] [Abstract][Full Text] [Related]
13. Generation of PDX-1 mutant porcine blastocysts by introducing CRISPR/Cas9-system into porcine zygotes via electroporation.
Tanihara F; Hirata M; Nguyen NT; Le QA; Hirano T; Takemoto T; Nakai M; Fuchimoto DI; Otoi T
Anim Sci J; 2019 Jan; 90(1):55-61. PubMed ID: 30368976
[TBL] [Abstract][Full Text] [Related]
14. Short homology-directed repair using optimized Cas9 in the pathogen Cryptococcus neoformans enables rapid gene deletion and tagging.
Huang MY; Joshi MB; Boucher MJ; Lee S; Loza LC; Gaylord EA; Doering TL; Madhani HD
Genetics; 2022 Jan; 220(1):. PubMed ID: 34791226
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA.
Toffaletti DL; Rude TH; Johnston SA; Durack DT; Perfect JR
J Bacteriol; 1993 Mar; 175(5):1405-11. PubMed ID: 8444802
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
Kim HM; Colaiácovo MP
Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
[TBL] [Abstract][Full Text] [Related]
17. Efficient Editing of the Nuclear
Guzmán-Zapata D; Sandoval-Vargas JM; Macedo-Osorio KS; Salgado-Manjarrez E; Castrejón-Flores JL; Oliver-Salvador MDC; Durán-Figueroa NV; Nogué F; Badillo-Corona JA
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871076
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
Schwartz C; Wheeldon I
Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
[TBL] [Abstract][Full Text] [Related]
19. High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k "Helper" Proteins.
Gwiazda KS; Grier AE; Sahni J; Burleigh SM; Martin U; Yang JG; Popp NA; Krutein MC; Khan IF; Jacoby K; Jensen MC; Rawlings DJ; Scharenberg AM
Mol Ther; 2016 Sep; 24(9):1570-80. PubMed ID: 27203437
[TBL] [Abstract][Full Text] [Related]
20. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
